Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
IPO
Pharma
RemeGen, Roche, Hengrui and more—Fierce Pharma Asia
Pfizer and RemeGen's HER2 ADC posted a phase 3 win. Roche plans to build a new Chinese plant. Hengrui gears up for a Hong Kong IPO. And more.
Angus Liu
May 16, 2025 10:20am
Takeda, AZ-Daiichi, Fosun-Henlius—Fierce Pharma Asia
Jan 24, 2025 8:55am
Indian CDMO Anthem Biosciences files for $397M IPO
Jan 8, 2025 3:05pm
Scilex Holding mulls spinoff, IPO for Scilex Pharma
Oct 16, 2024 11:20am
Stada charts strong first half of 2024 as owners weigh options
Aug 28, 2024 4:25pm
Galderma kicks off the process for $2.6B IPO
Mar 13, 2024 12:17pm
